methylene blue has been researched along with Amyotrophic Lateral Sclerosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Araújo Neto, EV; Madeira Alves, LCC; Martins Pontes, GI; Pacífico Feitosa, APO | 1 |
| Barrett, EF; Barrett, JN; Nonner, D; Talbot, JD; Wicomb, K; Zhang, Z | 1 |
| Akiyama, H; Arai, T; Bachurin, SO; Buchman, VL; Goedert, M; Hasegawa, M; Kametani, F; Ninkina, N; Nonaka, T; Yamashita, M | 1 |
| Lougheed, R; Turnbull, J | 1 |
| Audet, JN; Julien, JP; Soucy, G | 1 |
| Dibaj, P; Göricke, B; Hanisch, UK; Kirchhoff, F; Le Meur, K; Neusch, C; Scheffel, J; Schomburg, ED; Steffens, H; Weishaupt, JH; Zschüntzsch, J | 1 |
| Byers, PD; Page, KM | 1 |
7 other study(ies) available for methylene blue and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Antimicrobial photodynamic therapy associated with partial removal of carious tissue in a patient with amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Combined Modality Therapy; Dental Caries; Female; Humans; Low-Level Light Therapy; Methylene Blue; Middle Aged; Photochemotherapy; Photosensitizing Agents | 2018 |
Preservation of neuromuscular function in symptomatic SOD1-G93A mice by peripheral infusion of methylene blue.
Topics: Amyotrophic Lateral Sclerosis; Animals; Bungarotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Enzyme Inhibitors; Fluorescent Antibody Technique; Humans; Methylene Blue; Mice; Mice, Transgenic; Motor Endplate; Muscle Contraction; Neuromuscular Junction Diseases; Superoxide Dismutase | 2016 |
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Cell Line; Dementia; DNA-Binding Proteins; Enzyme Inhibitors; Humans; Inclusion Bodies; Indoles; Methylene Blue | 2009 |
Lack of effect of methylene blue in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Disease Progression; Female; Male; Methylene Blue; Mice; Mice, Congenic; Superoxide Dismutase; Superoxide Dismutase-1; Survival Analysis; Treatment Outcome | 2011 |
Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Blotting, Western; Disease Models, Animal; DNA-Binding Proteins; Drug Therapy, Combination; Enzyme Inhibitors; Immunohistochemistry; Lithium; Methylene Blue; Mice; Mice, Inbred C57BL; Mice, Transgenic; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1 | 2012 |
Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Cell Survival; Cytokines; Disease Models, Animal; Disease Progression; Female; Inflammation; Male; Methylene Blue; Mice; Microglia; Motor Activity; Motor Neurons; Superoxide Dismutase; Superoxide Dismutase-1; Time Factors | 2012 |
Axonic swellings demonstrated by a supravital methylene blue technique.
Topics: Aged; Amputation, Surgical; Amyotrophic Lateral Sclerosis; Anemia, Hypochromic; Axons; Bone Neoplasms; Chondrosarcoma; Diabetic Neuropathies; Edema; Glycosuria; Humans; Hyperglycemia; Injections, Intramuscular; Leg; Male; Methods; Methylene Blue; Motor Neurons; Muscles; Muscular Diseases; Neuritis; Neuromuscular Junction; Porphyrias; Staining and Labeling; Vitamin B Deficiency | 1969 |